Haseena Cassim

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial”.

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet(2021)10.1016/s0140-6736(21)00314-7

N/A

5.5DataRank · unranked

162 citations

Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti +39 more

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00061-9

N/A

1.1DataRank · unranked

30 citations

Lauren Ziemba, Sean S. Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje +95 more

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study

The Lancet HIV(2023)10.1016/s2352-3018(23)00107-8

N/A

0.675DataRank · unranked

13 citations

Jennifer J. Kiser, Lauren Ziemba, S. M. Ward, Yasha Rani, Tim R. Cressey +24 more

Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

The Lancet HIV(2025)10.1016/s2352-3018(24)00155-3

N/A

0.416DataRank · unranked

15 citations

Cissy Kityo, Moira J Spyer, Hilda A Mujuru, Immaculate Nankya, Adeodata R Kekitiinwa +21 more

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.101912

N/A

0.269DataRank · unranked

5 citations

Sylvia M. LaCourse, Daniel A. Enquobahrie, Barbra A. Richardson, Sarah Bradford, Grace Montepiedra +33 more

Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae308

N/A

0.180DataRank · unranked

2 citations

Krista S. Crider, Patricia DeMarrais, Sean S. Brummel, Mindy Zhang, Christine M Pfeiffer +17 more

Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003478

N/A

0.165DataRank · unranked

2 citations

Sean S. Brummel, Lauren Ziemba, John Shepherd, Tapiwa Mbengeranwa, Laarni Igawa +20 more

Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) Trial

JAIDS Journal of Acquired Immune Deficiency Syndromes(2025)10.1097/qai.0000000000003656

N/A

0DataRank · unranked

3 citations

Lauren Ziemba, Sean S. Brummel, Ben Johnston, Haseena Cassim, Gerhard Theron +9 more